Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Leiomyosarcoma - Overview
Leiomyosarcoma - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Leiomyosarcoma - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Leiomyosarcoma - Companies Involved in Therapeutics Development
Leiomyosarcoma - Drug Profiles
Leiomyosarcoma - Dormant Projects
Leiomyosarcoma - Discontinued Products
Leiomyosarcoma - Product Development Milestones
Featured News & Press Releases
Nov 18, 2020: PTC Therapeutics announces key regulatory desigtions for PTC596 to advance treatment of two rare oncology indications
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Leiomyosarcoma, 2022
Number of Products under Development by Companies, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Leiomyosarcoma, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Companies, 2022 (Contd..1)
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Companies, 2022 (Contd..2)
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Target, 2022 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Leiomyosarcoma - Pipeline by 3SBio Inc, 2022
Leiomyosarcoma - Pipeline by Actuate Therapeutics Inc, 2022
Leiomyosarcoma - Pipeline by Advenchen Laboratories LLC, 2022
Leiomyosarcoma - Pipeline by Agenus Inc, 2022
Leiomyosarcoma - Pipeline by Alphamab Oncology, 2022
Leiomyosarcoma - Pipeline by ALX Oncology Holdings Inc, 2022
Leiomyosarcoma - Pipeline by Apexigen Inc, 2022
Leiomyosarcoma - Pipeline by APIM Therapeutics AS, 2022
Leiomyosarcoma - Pipeline by Apollomics Inc, 2022
Leiomyosarcoma - Pipeline by AstraZeneca Plc, 2022
Leiomyosarcoma - Pipeline by Atara Biotherapeutics Inc, 2022
Leiomyosarcoma - Pipeline by BeiGene Ltd, 2022
Leiomyosarcoma - Pipeline by BioAtla Inc, 2022
Leiomyosarcoma - Pipeline by BioMed Valley Discoveries Inc, 2022
Leiomyosarcoma - Pipeline by Calithera Biosciences Inc, 2022
Leiomyosarcoma - Pipeline by Cebiotex SL, 2022
Leiomyosarcoma - Pipeline by Clovis Oncology Inc, 2022
Leiomyosarcoma - Pipeline by CStone Pharmaceuticals Co Ltd, 2022
Leiomyosarcoma - Pipeline by Eli Lilly and Co, 2022
Leiomyosarcoma - Pipeline by ENB Therapeutics LLC, 2022
Leiomyosarcoma - Pipeline by EUSA Pharma (UK) Ltd, 2022
Leiomyosarcoma - Pipeline by Exelixis Inc, 2022
Leiomyosarcoma - Pipeline by F. Hoffmann-La Roche Ltd, 2022
Leiomyosarcoma - Pipeline by Immix BioPharma Inc, 2022
Leiomyosarcoma - Pipeline by Immodulon Therapeutics Ltd, 2022
Leiomyosarcoma - Pipeline by Incyte Corp, 2022
Leiomyosarcoma - Pipeline by Karyopharm Therapeutics Inc, 2022
Leiomyosarcoma - Pipeline by Kuur Therapeutics Ltd, 2022
Leiomyosarcoma - Pipeline by Merck & Co Inc, 2022
Leiomyosarcoma - Pipeline by Merck KGaA, 2022
Leiomyosarcoma - Pipeline by Ono Pharmaceutical Co Ltd, 2022
Leiomyosarcoma - Pipeline by Pfizer Inc, 2022
Leiomyosarcoma - Pipeline by Pharma Mar SA, 2022
Leiomyosarcoma - Pipeline by Philogen SpA, 2022
Leiomyosarcoma - Pipeline by PTC Therapeutics Inc, 2022
Leiomyosarcoma - Pipeline by Shanghai De Novo Pharmatech Co Ltd, 2022
Leiomyosarcoma - Pipeline by Shanghai Junshi Bioscience Co Ltd, 2022
Leiomyosarcoma - Pipeline by Tactical Therapeutics Inc, 2022
Leiomyosarcoma - Pipeline by Tempest Therapeutics Inc, 2022
Leiomyosarcoma - Pipeline by Tessa Therapeutics Ltd, 2022
Leiomyosarcoma - Pipeline by Viracta Therapeutics Inc, 2022
Leiomyosarcoma - Pipeline by Y-mAbs Therapeutics Inc, 2022
Leiomyosarcoma - Pipeline by Yooyoung Pharm Co Ltd, 2022
Leiomyosarcoma - Dormant Projects, 2022
Leiomyosarcoma - Discontinued Products, 2022